Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers

Rixt A. Wijma, Angela Huttner, Sven van Dun, Wendy Kloezen, Iain J. Abbott, Anouk E. Muller, Birgit C.P. Koch, Johan W. Mouton

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Given emerging uropathogen resistance to more recent antibiotics, old antibiotics used for uncomplicated urinary tract infection (UTI) warrant re-examination. In this study, the urinary antibacterial activities of fosfomycin and nitrofurantoin were investigated by determining the urinary inhibitory titre and urinary bactericidal titre against uropathogens in urine samples from female volunteers following administration of single-dose fosfomycin (3 g) or nitrofurantoin (50 mg q6h or 100 mg q8h). Urine samples were collected over 48 h (fosfomycin) or 6 or 8 h (nitrofurantoin), with drug levels quantified with every void. Fosfomycin concentrations ranged from <0.75 mg/L [lower limit of quantification (LLOQ)] to 5729.9 mg/L and nitrofurantoin concentrations ranged from <4 mg/L (LLOQ) to 176.3 mg/L (50 mg q6h) or 209.4 mg/L (100 mg q8h). There was discrepancy in the response to fosfomycin between Escherichia coli and Klebsiella pneumoniae, with fosfomycin displaying strong bactericidal activity for 48 h against E. coli but moderate bactericidal activity for 18 h against K. pneumoniae. This effect was not related to the strain's baseline minimum inhibitory concentration but rather to the presence of a resistant subpopulation. Maximum titres of nitrofurantoin were obtained during the first 2 h, but no antibacterial effect was found in most samples regardless of the dose. In the rare samples in which antibacterial activity was detectable, titres were comparable for both species tested. These findings confirm doubts regarding fosfomycin administration in UTIs caused by K. pneumoniae and reveal a discrepancy between nitrofurantoin's measurable ex vivo activity and its clinical effect over multiple dosing intervals.

Original languageEnglish
Pages (from-to)435-441
Number of pages7
JournalInternational Journal of Antimicrobial Agents
Volume54
Issue number4
DOIs
Publication statusPublished - 1 Oct 2019

Keywords

  • Fosfomycin
  • Healthy volunteers
  • Nitrofurantoin
  • Pharmacodynamics
  • Pharmacokinetics
  • Urinary tract infection

Cite this

Wijma, Rixt A. ; Huttner, Angela ; van Dun, Sven ; Kloezen, Wendy ; Abbott, Iain J. ; Muller, Anouk E. ; Koch, Birgit C.P. ; Mouton, Johan W. / Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers. In: International Journal of Antimicrobial Agents. 2019 ; Vol. 54, No. 4. pp. 435-441.
@article{a8c1236dce4d42b09d797777cc70346f,
title = "Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers",
abstract = "Given emerging uropathogen resistance to more recent antibiotics, old antibiotics used for uncomplicated urinary tract infection (UTI) warrant re-examination. In this study, the urinary antibacterial activities of fosfomycin and nitrofurantoin were investigated by determining the urinary inhibitory titre and urinary bactericidal titre against uropathogens in urine samples from female volunteers following administration of single-dose fosfomycin (3 g) or nitrofurantoin (50 mg q6h or 100 mg q8h). Urine samples were collected over 48 h (fosfomycin) or 6 or 8 h (nitrofurantoin), with drug levels quantified with every void. Fosfomycin concentrations ranged from <0.75 mg/L [lower limit of quantification (LLOQ)] to 5729.9 mg/L and nitrofurantoin concentrations ranged from <4 mg/L (LLOQ) to 176.3 mg/L (50 mg q6h) or 209.4 mg/L (100 mg q8h). There was discrepancy in the response to fosfomycin between Escherichia coli and Klebsiella pneumoniae, with fosfomycin displaying strong bactericidal activity for 48 h against E. coli but moderate bactericidal activity for 18 h against K. pneumoniae. This effect was not related to the strain's baseline minimum inhibitory concentration but rather to the presence of a resistant subpopulation. Maximum titres of nitrofurantoin were obtained during the first 2 h, but no antibacterial effect was found in most samples regardless of the dose. In the rare samples in which antibacterial activity was detectable, titres were comparable for both species tested. These findings confirm doubts regarding fosfomycin administration in UTIs caused by K. pneumoniae and reveal a discrepancy between nitrofurantoin's measurable ex vivo activity and its clinical effect over multiple dosing intervals.",
keywords = "Fosfomycin, Healthy volunteers, Nitrofurantoin, Pharmacodynamics, Pharmacokinetics, Urinary tract infection",
author = "Wijma, {Rixt A.} and Angela Huttner and {van Dun}, Sven and Wendy Kloezen and Abbott, {Iain J.} and Muller, {Anouk E.} and Koch, {Birgit C.P.} and Mouton, {Johan W.}",
year = "2019",
month = "10",
day = "1",
doi = "10.1016/j.ijantimicag.2019.07.018",
language = "English",
volume = "54",
pages = "435--441",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier - Mosby",
number = "4",

}

Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers. / Wijma, Rixt A.; Huttner, Angela; van Dun, Sven; Kloezen, Wendy; Abbott, Iain J.; Muller, Anouk E.; Koch, Birgit C.P.; Mouton, Johan W.

In: International Journal of Antimicrobial Agents, Vol. 54, No. 4, 01.10.2019, p. 435-441.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers

AU - Wijma, Rixt A.

AU - Huttner, Angela

AU - van Dun, Sven

AU - Kloezen, Wendy

AU - Abbott, Iain J.

AU - Muller, Anouk E.

AU - Koch, Birgit C.P.

AU - Mouton, Johan W.

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Given emerging uropathogen resistance to more recent antibiotics, old antibiotics used for uncomplicated urinary tract infection (UTI) warrant re-examination. In this study, the urinary antibacterial activities of fosfomycin and nitrofurantoin were investigated by determining the urinary inhibitory titre and urinary bactericidal titre against uropathogens in urine samples from female volunteers following administration of single-dose fosfomycin (3 g) or nitrofurantoin (50 mg q6h or 100 mg q8h). Urine samples were collected over 48 h (fosfomycin) or 6 or 8 h (nitrofurantoin), with drug levels quantified with every void. Fosfomycin concentrations ranged from <0.75 mg/L [lower limit of quantification (LLOQ)] to 5729.9 mg/L and nitrofurantoin concentrations ranged from <4 mg/L (LLOQ) to 176.3 mg/L (50 mg q6h) or 209.4 mg/L (100 mg q8h). There was discrepancy in the response to fosfomycin between Escherichia coli and Klebsiella pneumoniae, with fosfomycin displaying strong bactericidal activity for 48 h against E. coli but moderate bactericidal activity for 18 h against K. pneumoniae. This effect was not related to the strain's baseline minimum inhibitory concentration but rather to the presence of a resistant subpopulation. Maximum titres of nitrofurantoin were obtained during the first 2 h, but no antibacterial effect was found in most samples regardless of the dose. In the rare samples in which antibacterial activity was detectable, titres were comparable for both species tested. These findings confirm doubts regarding fosfomycin administration in UTIs caused by K. pneumoniae and reveal a discrepancy between nitrofurantoin's measurable ex vivo activity and its clinical effect over multiple dosing intervals.

AB - Given emerging uropathogen resistance to more recent antibiotics, old antibiotics used for uncomplicated urinary tract infection (UTI) warrant re-examination. In this study, the urinary antibacterial activities of fosfomycin and nitrofurantoin were investigated by determining the urinary inhibitory titre and urinary bactericidal titre against uropathogens in urine samples from female volunteers following administration of single-dose fosfomycin (3 g) or nitrofurantoin (50 mg q6h or 100 mg q8h). Urine samples were collected over 48 h (fosfomycin) or 6 or 8 h (nitrofurantoin), with drug levels quantified with every void. Fosfomycin concentrations ranged from <0.75 mg/L [lower limit of quantification (LLOQ)] to 5729.9 mg/L and nitrofurantoin concentrations ranged from <4 mg/L (LLOQ) to 176.3 mg/L (50 mg q6h) or 209.4 mg/L (100 mg q8h). There was discrepancy in the response to fosfomycin between Escherichia coli and Klebsiella pneumoniae, with fosfomycin displaying strong bactericidal activity for 48 h against E. coli but moderate bactericidal activity for 18 h against K. pneumoniae. This effect was not related to the strain's baseline minimum inhibitory concentration but rather to the presence of a resistant subpopulation. Maximum titres of nitrofurantoin were obtained during the first 2 h, but no antibacterial effect was found in most samples regardless of the dose. In the rare samples in which antibacterial activity was detectable, titres were comparable for both species tested. These findings confirm doubts regarding fosfomycin administration in UTIs caused by K. pneumoniae and reveal a discrepancy between nitrofurantoin's measurable ex vivo activity and its clinical effect over multiple dosing intervals.

KW - Fosfomycin

KW - Healthy volunteers

KW - Nitrofurantoin

KW - Pharmacodynamics

KW - Pharmacokinetics

KW - Urinary tract infection

UR - http://www.scopus.com/inward/record.url?scp=85071940506&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2019.07.018

DO - 10.1016/j.ijantimicag.2019.07.018

M3 - Article

VL - 54

SP - 435

EP - 441

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 4

ER -